fractional exhaled nitric oxide

DIAGNOSTIC_TEST3 trials

Sponsors

Rambam Health Care Campus, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Heidelberg University

Conditions

Bronchial HyperreactivityCOPDCOPD, Early-OnsetChronic Heart DiseaseChronic Lung DiseaseDyspnea; UremicEnd Stage Renal DiseaseHemodialysis-Induced Symptom

Unknown Phase

Prospective Evaluation of the Efficacy of Palivizumab Administration in Children Born at 29-32 Weeks of Gestation

CompletedNCT01269528

Rambam Health Care CampusBronchial Hyperreactivity, Infant, Premature

Start: 2013-08-31End: 2015-08-31Updated: 2015-11-10

Dyspnea Assessment in Hemodialysis Patients

CompletedNCT03773991

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sChronic Heart Disease, Chronic Lung Disease, Dyspnea; Uremic +3

Start: 2019-03-29End: 2020-02-25Updated: 2024-08-15

Change in Airway Peripheral Tone in COPD

Heidelberg UniversityCOPD, COPD, Early-Onset

Start: 2019-11-19End: 2023-06-30Updated: 2021-07-14